JENNIFER MCCOY: Open Payments
NPI 1811021124 · ROARING SPRING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,230 in 68 payments from 19 companies in 2025. Trend: 2023 $969 · 2024 $1,113 · 2025 $1,230
Food & beverage: $1,189Education: $40
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $217 |
| ABBVIE INC. | 12 | $175 |
| AstraZeneca Pharmaceuticals LP | 4 | $149 |
| Lilly USA, LLC | 7 | $137 |
| Abbott Laboratories | 5 | $85 |
| PFIZER INC. | 4 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
| Axsome Therapeutics, Inc. | 3 | $61 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $46 |
| Lundbeck LLC | 2 | $41 |
Products named: Ozempic, MOUNJARO, AIRSUPRA, FREESTYLE LIBRE 3, Kerendia, Symbravo, UBRELVY, NURTEC ODT.
Industry payments across PA — which companies pay providers there.
